These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 37500964)

  • 1. Consensus report from the 10th Global Forum for Liver Magnetic Resonance Imaging: developments in HCC management.
    Taouli B; Ba-Ssalamah A; Chapiro J; Chhatwal J; Fowler K; Kang TW; Knobloch G; Koh DM; Kudo M; Lee JM; Murakami T; Pinato DJ; Ringe KI; Song B; Tabrizian P; Wang J; Yoon JH; Zeng M; Zhou J; Vilgrain V
    Eur Radiol; 2023 Dec; 33(12):9152-9166. PubMed ID: 37500964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consensus report from the 10th global forum for liver magnetic resonance imaging: multidisciplinary team discussion.
    Taouli B; Ba-Ssalamah A; Chapiro J; Chhatwal J; Fowler K; Kang TW; Knobloch G; Koh DM; Kudo M; Lee JM; Murakami T; Pinato DJ; Ringe KI; Song B; Tabrizian P; Wang J; Yoon JH; Zeng M; Zhou J; Vilgrain V
    Eur Radiol; 2023 Dec; 33(12):9167-9181. PubMed ID: 37439935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consensus report from the 9
    Koh DM; Ba-Ssalamah A; Brancatelli G; Fananapazir G; Fiel MI; Goshima S; Ju SH; Kartalis N; Kudo M; Lee JM; Murakami T; Seidensticker M; Sirlin CB; Tan CH; Wang J; Yoon JH; Zeng M; Zhou J; Taouli B
    Eur Radiol; 2021 Aug; 31(8):5615-5628. PubMed ID: 33523304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consensus report from the 8th International Forum for Liver Magnetic Resonance Imaging.
    Zech CJ; Ba-Ssalamah A; Berg T; Chandarana H; Chau GY; Grazioli L; Kim MJ; Lee JM; Merkle EM; Murakami T; Ricke J; B Sirlin C; Song B; Taouli B; Yoshimitsu K; Koh DM
    Eur Radiol; 2020 Jan; 30(1):370-382. PubMed ID: 31385048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of Hepatocellular Carcinoma with Gadoxetic Acid-Enhanced MRI: 2016 Consensus Recommendations of the Korean Society of Abdominal Radiology.
    Korean Society of Abdominal Radiology
    Korean J Radiol; 2017; 18(3):427-443. PubMed ID: 28458595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of gadoxetic acid MRI and diffusion-weighted imaging for the diagnosis of early recurrence of hepatocellular carcinoma.
    Rimola J; Forner A; Sapena V; Llarch N; Darnell A; Díaz A; García-Criado A; Bianchi L; Vilana R; Díaz-González Á; Ayuso C; Bruix J; Reig M
    Eur Radiol; 2020 Jan; 30(1):186-194. PubMed ID: 31372783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings.
    Lee DH; Lee JM; Baek JH; Shin CI; Han JK; Choi BI
    Radiology; 2015 Jan; 274(1):149-60. PubMed ID: 25203131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consensus report from the 7th International Forum for Liver Magnetic Resonance Imaging.
    Merkle EM; Zech CJ; Bartolozzi C; Bashir MR; Ba-Ssalamah A; Huppertz A; Lee JM; Ricke J; Sakamoto M; Sirlin CB; Ye SL; Zeng M
    Eur Radiol; 2016 Mar; 26(3):674-82. PubMed ID: 26070500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of recurrent hepatocellular carcinoma after surgical resection: Non-contrast liver MR imaging with diffusion-weighted imaging versus gadoxetic acid-enhanced MR imaging.
    Min JH; Kim YK; Choi SY; Kang TW; Jeong WK; Kim K; Won HJ
    Br J Radiol; 2018 Oct; 91(1090):20180177. PubMed ID: 29927634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performing Gadoxetic Acid-Enhanced MRI After CT for Guiding Curative Treatment of Early-Stage Hepatocellular Carcinoma: A Cost-Effectiveness Analysis.
    Suh CH; Kim KW; Park SH; Kim SY; Woo DC; Shin S; Pyo J; Shinagare AB; Ramaiya NH; Lim YS
    AJR Am J Roentgenol; 2018 Feb; 210(2):W63-W69. PubMed ID: 29091004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of diagnostic performance of non-contrast MRI and abbreviated MRI using gadoxetic acid in initially diagnosed hepatocellular carcinoma patients: a simulation study of surveillance for hepatocellular carcinomas.
    Whang S; Choi MH; Choi JI; Youn SY; Kim DH; Rha SE
    Eur Radiol; 2020 Aug; 30(8):4150-4163. PubMed ID: 32166493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of small hepatocellular carcinoma using gadoxetic acid-enhanced MRI: Is the addition of diffusion-weighted MRI at 3.0T beneficial?
    Zhao XT; Li WX; Chai WM; Chen KM
    J Dig Dis; 2014 Mar; 15(3):137-45. PubMed ID: 24354621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of small hepatocellular carcinoma: can gadoxetic acid-enhanced magnetic resonance imaging replace combining gadopentetate dimeglumine-enhanced and superparamagnetic iron oxide-enhanced magnetic resonance imaging?
    Kim YK; Kim CS; Han YM; Park G
    Invest Radiol; 2010 Nov; 45(11):740-6. PubMed ID: 20644488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A radiomics-based biomarker for cytokeratin 19 status of hepatocellular carcinoma with gadoxetic acid-enhanced MRI.
    Wang W; Gu D; Wei J; Ding Y; Yang L; Zhu K; Luo R; Rao SX; Tian J; Zeng M
    Eur Radiol; 2020 May; 30(5):3004-3014. PubMed ID: 32002645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suboptimal performance of LI-RADS v2018 on gadoxetic acid-enhanced MRI for detecting hepatocellular carcinoma in liver transplant candidates.
    Oh NE; Choi SH; Kim S; Lee H; Jang HJ; Byun JH; Won HJ; Shin YM
    Eur Radiol; 2024 Jan; 34(1):465-474. PubMed ID: 37532900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Performance of 2018 KLCA-NCC Practice Guideline for Hepatocellular Carcinoma on Gadoxetic Acid-Enhanced MRI in Patients with Chronic Hepatitis B or Cirrhosis: Comparison with LI-RADS Version 2018.
    Lee SM; Lee JM; Ahn SJ; Kang HJ; Yang HK; Yoon JH
    Korean J Radiol; 2021 Jul; 22(7):1066-1076. PubMed ID: 33739633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of postoperative liver failure using gadoxetic acid-enhanced magnetic resonance imaging in patients with hepatocellular carcinoma.
    Jin YJ; Lee SH; Cho SG; Kim JH; Lee JW; Lee KY; Shin WY
    J Gastroenterol Hepatol; 2016 Jul; 31(7):1349-56. PubMed ID: 26916616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of international guidelines for diagnosis of hepatocellular carcinoma and implications for transplant allocation in liver transplantation candidates with gadoxetic acid enhanced liver MRI versus contrast enhanced CT: a prospective study with liver explant histopathological correlation.
    Odedra D; Jandaghi AB; Bhayana R; Elbanna KY; Espin-Garcia O; Fischer SE; Ghanekar A; Sapisochin G; Jhaveri KS
    Cancer Imaging; 2022 Oct; 22(1):55. PubMed ID: 36195953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic performance of gadoxetic acid-enhanced abbreviated magnetic resonance imaging protocol in small hepatocellular carcinoma (≤2 cm) in high-risk patients.
    Wang JH; Qiu QS; Dong SY; Chen XS; Wang WT; Yang YT; Sun W; Rao SX
    Acta Radiol; 2023 Oct; 64(10):2687-2696. PubMed ID: 37691270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of gadoxetic acid-enhanced MRI and diffusion-weighted imaging in the differentiation of hypervascular hyperplastic nodule from small (<3 cm) hypervascular hepatocellular carcinoma in patients with alcoholic liver cirrhosis: A retrospective case-control study.
    Kim SS; Kim SH; Song KD; Choi SY; Heo NH
    J Magn Reson Imaging; 2020 Jan; 51(1):70-80. PubMed ID: 31062483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.